Johns Hopkins Center for Psychedelic and Consciousness Research advances clinical studies of psilocybin and related compounds across depression, addiction, pain, and spiritual experience

Johns Hopkins Center for Psychedelic and Consciousness Research conducts and supports scientific work on psychedelics, with a strong emphasis on psilocybin and its effects on mental health, behavior, and conscious experience. The center presents psychedelic research as a rigorous academic field spanning depression, addiction, anxiety, pain, cognition, meditation, and spirituality. Clinical studies, publications, training, philanthropy, and public education form the main pillars of the center's work. Investigators associated with the program are known for landmark modern trials that helped return psychedelics to mainstream biomedical research and for studying both therapeutic outcomes and meaningful subjective effects. The broader significance lies in linking neuroscience, psychiatry, and consciousness research within a major medical institution. That framing positions psychedelics not only as potential treatments, but also as tools for investigating human perception, mystical-type experience, and long-term psychological change.